The safety and efficacy of treatment with P2Y12 adenosine‐diphosphate receptor inhibitors (P2Y12‐RI) before coronary angiography among patients with non‐ST‐segment elevation acute coronary syndromes (NSTEACS) are questionable. Click to show full abstract
The safety and efficacy of treatment with P2Y12 adenosine‐diphosphate receptor inhibitors (P2Y12‐RI) before coronary angiography among patients with non‐ST‐segment elevation acute coronary syndromes (NSTEACS) are questionable.
Keywords:
patients non;
among patients;
receptor inhibitors;
acute coronary;
p2y12 adenosine;
elevation acute
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!